Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Ann Neurol. 2022 Jul 29;92(4):650–662. doi: 10.1002/ana.26453

Figure 2. Differences in neuropathology scores between synuclein-pathology groups as a function of SAA result.

Figure 2.

Bars represent the distribution of SAA positive or SAA negative within high (“H”) or low (“L”) categorization of ADNC, Braak, Thal, and Cerad neuropathological staging. Patients are further classified by limbic/neocortical (“L/N”) or amygdala-predominant (“A”) groups. Statistical analysis using Fisher’s exact test within synuclein-pathology group.